NVRO's fourth-quarter earnings surpass the Zacks Consensus Estimate, while worldwide revenues decline year over year. The ...

Dr. Conner is the only surgeon in Connecticut performing an innovative procedure involving a facial nerve stimulator, a groundbreaking alternative for ...

Company Achieves Key Clinical Milestone with more than 20 Patients Enrolled in Weekly Dosing Cohort of Phase 1 Trial of Decoy20Pharmacodynamic ...

Hyderabad: The negligence of police in not conducting a drunk driving test on a GHMC garbage tipper driver involved in a fatal accident in Secunderaba.

U.S. revenue in the fourth quarter of 2024 was $91.4 million, a decrease of 9.9% compared with $101.5 million in the prior year period. U.S. permanent implant procedures decreased by 7.0% compared ...

Doctors have offered deep brain stimulation to Parkinson’s patients since 2002. But until now, devices have only provided continuous stimulation—not the dynamic and responsive activation that the ...

Revelation Neuro, Inc. is focused on advancing development of a Non-Implantable Artificial Intelligence (“AI”) Powered BCI ...

There is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain stimulator that ... multi-center trial to test the device.

Referring to Section 41 of Code of Criminal Procedure (CrPC), he said it was ... he said while criticising the ongoing trend of trial on social media. "Every citizen has right to criticise judgements.

Nevro Corp (NYSE:NVRO), a medical device company specializing in spinal cord stimulation (SCS) technology for chronic pain treatment, has recently undergone significant changes in its market position ...